Skip to content

Net margin at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
55.9%+35.7pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-612%+602pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-125.9%-54.5pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-30.9%-10.5pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
37.1%+0.2pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-2,747.2%-1,328pp

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.24B+128%
Enterprise value$4.06B+139%
P/E58×
P/S5.6×+1.8×

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0.0×
Current ratio3.8×+0.1×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

Based on trailing twelve months.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's net margin?
Kiniksa Pharmaceuticals International, plc (KNSA) reported net margin of 9.7% in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's net margin changed year-over-year?
Kiniksa Pharmaceuticals International, plc's net margin increased by 375.0% year-over-year, from -3.5% to 9.7%.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's net margin?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's net margin has grown at a -61.8% compound annual growth rate (CAGR), from -409.7% to 8.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.